The use of acellular dermal matrix as a scaffold for periosteum replacement.
Three preclinical models were used to evaluate GraftJacket Acellular Periosteum Replacement Scaffold (Wright Medical Technology, Inc, Arlington, Tenn). The studies assessed the ability of the acellular dermal matrix to repopulate with cells, revascularize, provide a protected environment for bone defect restoration, and minimize fibrous tissue infiltration. An athymic nude rat muscle implantation study demonstrated a steady increase in cellular repopulation through days 2-21. The formation of blood vessels occurred between days 7-14 in this study. Results from a porcine femoral drill hole study indicated that the scaffold material was intact and adherent to surrounding bone and allowed cellular repopulation and vascular infiltration at a 5-week time period. A preliminary porcine segmental bone defect model at a 6-week time period demonstrated the ability of the scaffold material to protect the bone defect site as revealed by new bone formation within the margins of the defect and adjacent to the scaffold. The segmental model also indicated minimal to no soft tissue invasion into the defect site. The combined studies provided preliminary evidence that the dermal membrane material may be used as a scaffold for periosteum regeneration by allowing for cellular repopulation, revascularization, and bone defect restoration.
Beniker
Dan
D
LifeCell, Branchburg, NJ, USA.
McQuillan
David
D
Livesey
Stephen
S
Urban
Robert M
RM
Turner
Thomas M
TM
Blum
Barbara
B
Hughes
Kim
K
Haggard
Warren O
WO
D000818:Animals; D001672:Biocompatible Materials; D001857:Bone Matrix / Q000637:transplantation*; D005269:Femur / Q000473:pathology / Q000502:physiology*; D008297:Male; D023421:Models, Animal; D010521:Periosteum / Q000502:physiology*; D051381:Rats; D012038:Regeneration; D013552:Swine; D014182:Transplantation, Autologous
D001672:Biocompatible Materials